Cost of invasive pneumococcal disease, all-cause pneumonia, and all-cause otitis media among commercial-insured US children
Costs of IPD, all-cause PNE, and all-cause OM are high, particularly in the hospital setting. All-cause PNE, one of the most common causes of hospitalization for children, is particularly costly for children with comorbidities.
Authors
- Jeffrey Vietri (ORCID: https://orcid.org/0000-0002-5610-3098)
- Derek Weycker (ORCID: https://orcid.org/0000-0002-5405-2215)
- Adriano Arguedas Mohs
- Alexander Lonshteyn (ORCID: https://orcid.org/0000-0003-0203-2762)
- Stephen I. Pelton (ORCID: https://orcid.org/0000-0003-4862-5344)
- Ahuva Averin (ORCID: https://orcid.org/0000-0002-4490-7021)
- Rotem Lapidot (ORCID: https://orcid.org/0000-0002-4398-1588)
- Liping Huang (ORCID: https://orcid.org/0000-0003-3073-7698)
- Alejandro Cané (ORCID: https://orcid.org/0000-0003-0778-6862)
- Mark H. Rozenbaum (ORCID: https://orcid.org/0000-0001-6209-4370)
Institutions
- Boston University (US)
- Boston Medical Center (US)
- Technion – Israel Institute of Technology (IL)
- Pfizer (United States) (US)
- Rambam Health Care Campus (IL)
- Prevea Health (US)
- Pfizer (Netherlands) (NL)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1080/13696998.2025.2484919
- Citations
- 2
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 2.71